Atezolizumab (Tecentriq®) accepted for use within NHS Scotland

Approved for use in combination with carboplatin & etoposide for 1st line treatment of adult patients with extensive-stage small cell lung cancer. RCT reported regimen linked to modest significant improvements in progression free survival & overall survival vs chemotherapy alone

Scottish Medicines Consortium